Ustekinumab With Semi-EN vs Exclusive EN for Preoperative Crohn's Disease Optimization.
NCT06912815
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
184
Enrollment
OTHER
Sponsor class
Conditions
Crohn Disease (CD)
Interventions
BIOLOGICAL:
ustekinumab and semi enteral nutrition
OTHER:
Exclusive enteral nutrition
Sponsor
Xiang Gao